Thus, in this study, we performed the expression profile analyses of the TMPRSS2 gene for COVID‐19 in different normal tissues and PRAD (prostate adenocarcinoma) tumour tissues as a marker for targeted therapy.19, 20, 21. The gene discussed is TMPRSS2; the disease is prostate adenocarcinoma.